Quantbot Technologies LP Ptc Therapeutics, Inc. Transaction History

Quantbot Technologies LP

$2.5 Billion
Q4 2024

A detailed history of Quantbot Technologies LP transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Quantbot Technologies LP holds 101 shares of PTCT stock, worth $5,107. This represents 0.0% of its overall portfolio holdings.

Number of Shares

101

Holding current value

$5,107

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$34.99 - $52.07 $3,533 - $5,259	101 New	101 $4,000
Q1 2024 May 06, 2024	BUY	$24.15 - $31.95 $132,825 - $175,725	5,500 New	5,500 $159,000
Q3 2022 Nov 07, 2022	BUY	$41.85 - $53.85 $8,370 - $10,770	200 New	200 $10,000
Q1 2021 May 14, 2021	SELL	$46.8 - $68.92 $11,512 - $16,954	-246 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$47.96 - $67.64 $10,838 - $15,286	226 Added 1130.0%	246 $15,000
Q3 2020 Nov 16, 2020	BUY	$45.41 - $57.07 $908 - $1,141	20 New	20 $0
Q1 2020 May 13, 2020	SELL	$32.37 - $59.36 $4,726 - $8,666	-146 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$32.22 - $50.07 $4,704 - $7,310	146 New	146 $7,000
Q4 2018 Feb 13, 2019	SELL	$29.83 - $46.51 $81,406 - $126,925	-2,729 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$33.9 - $47.77 $82,987 - $116,940	2,448 Added 871.17%	2,729 $128,000
Q2 2018 Aug 13, 2018	BUY	$25.7 - $47.88 $7,221 - $13,454	281 New	281 $9,000
Q1 2018 May 11, 2018	SELL	$17.46 - $32.59 $18,629 - $34,773	-1,067 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$15.14 - $20.89 $97,425 - $134,427	-6,435 Reduced 85.78%	1,067 $17,000
Q3 2017 Nov 07, 2017	BUY	$16.81 - $21.61 $126,108 - $162,118	7,502	7,502 $150,000

Others Institutions Holding PTCT

# of Institutions

257

Shares Held

77.3M

Call Options Held

179K

Put Options Held

536K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.62B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Account

Quantbot Technologies LP Ptc Therapeutics, Inc. Transaction History